KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Asset Utilization Ratio (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.51 as the latest value for Q1 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.51 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.51, a N/A change, with the full-year FY2025 number at 0.53, changed N/A from a year prior.
  • Asset Utilization Ratio was 0.51 for Q1 2025 at Bristol Myers Squibb, down from 0.52 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.52 in Q4 2024 to a low of 0.37 in Q1 2021.
  • A 4-year average of 0.46 and a median of 0.47 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: grew 20.89% in 2021, then rose 12.37% in 2022.
  • Bristol Myers Squibb's Asset Utilization Ratio stood at 0.42 in 2021, then grew by 12.37% to 0.47 in 2022, then grew by 9.55% to 0.52 in 2024, then dropped by 0.71% to 0.51 in 2025.
  • Per Business Quant, the three most recent readings for BMY's Asset Utilization Ratio are 0.51 (Q1 2025), 0.52 (Q4 2024), and 0.47 (Q4 2022).